coding.bio
Curated by SignalAI-assisted platform for cell therapy development
Overview
AI-assisted platform for cell therapy development. The platform utilizes machine learning technology to screen and identify lead candidates (Chimeric Antigen Receptors) for cell therapy. It uses automation & computation technology for the identification of Chimeric Antigen Receptor (CRAs) for therapeutics.
Key facts
- Founded
- 2021
- Headquarters
- Oxford, United Kingdom
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view